Corient Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Corient Capital Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$375K	Hold	19,092	–	–	0.03%	403
2022 Q2	$375K	Sell	19,092 -2,116	-10%	-$50.1K	0.03%	418
2022 Q1	$553K	Sell	21,208 -1,520	-7%	-$40.5K	0.04%	363
2021 Q4	$645K	Sell	22,728 -5,141	-18%	-$160K	0.04%	322
2021 Q3	$889K	Sell	27,869 -1,216	-4%	-$40.8K	0.07%	232
2021 Q2	$1.01M	Sell	29,085 -20	-0.1%	-$660	0.07%	212
2021 Q1	$858K	Buy	29,105 +2,472	+9%	+$76K	0.07%	217
2020 Q4	$817K	Buy	26,633 +1,349	+5%	+$41.2K	0.08%	201
2020 Q3	$706K	Sell	25,284 -5,100	-17%	-$129K	0.08%	209
2020 Q2	$652K	Buy	+30,384	New	+$671K	0.08%	218

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Corient Capital Partners's ELAN Position: Q3 2022 in Review

Corient Capital Partners held its Elanco Animal Health (ELAN) position steady in Q3 2022 at 19,092 shares worth $375K. The position accounts for 0.03% of the portfolio, ranked #403.

Corient Capital Partners first reported a position in ELAN in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.01M in Q2 2021. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

Corient Capital Partners held 19,092 shares of Elanco Animal Health worth $375K as of Q3 2022.
Corient Capital Partners left its Elanco Animal Health share count unchanged in Q3 2022.
Elanco Animal Health made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #403 holding.
Corient Capital Partners first reported a position in Elanco Animal Health in Q2 2020 and has held it in 10 quarters since.
Corient Capital Partners's Elanco Animal Health position peaked at $1.01M in Q2 2021.
419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.